Cambiar Investors LLC Sells 9,782 Shares of JPMorgan Chase & Co. (NYSE:JPM)

Cambiar Investors LLC lowered its position in shares of JPMorgan Chase & Co. (NYSE:JPM - Free Report) by 4.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 226,329 shares of the financial services provider's stock after selling 9,782 shares during the quarter. JPMorgan Chase & Co. accounts for about 2.2% of Cambiar Investors LLC's holdings, making the stock its 13th largest position. Cambiar Investors LLC's holdings in JPMorgan Chase & Co. were worth $54,253,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the company. Mizuho Securities Co. Ltd. purchased a new position in JPMorgan Chase & Co. during the third quarter valued at approximately $25,000. Catalyst Capital Advisors LLC purchased a new position in JPMorgan Chase & Co. during the third quarter valued at approximately $27,000. New England Capital Financial Advisors LLC grew its position in JPMorgan Chase & Co. by 38.5% during the third quarter. New England Capital Financial Advisors LLC now owns 180 shares of the financial services provider's stock valued at $38,000 after purchasing an additional 50 shares in the last quarter. Carolina Wealth Advisors LLC grew its position in JPMorgan Chase & Co. by 36.0% during the third quarter. Carolina Wealth Advisors LLC now owns 189 shares of the financial services provider's stock valued at $40,000 after purchasing an additional 50 shares in the last quarter. Finally, Peterson Financial Group Inc. purchased a new position in JPMorgan Chase & Co. during the third quarter valued at approximately $45,000. Institutional investors and hedge funds own 71.55% of the company's stock.

Insider Activity at JPMorgan Chase & Co.

In other news, General Counsel Stacey Friedman sold 3,303 shares of the stock in a transaction on Thursday, January 16th. The shares were sold at an average price of $253.94, for a total value of $838,763.82. Following the completion of the transaction, the general counsel now owns 47,620 shares in the company, valued at approximately $12,092,622.80. This represents a 6.49 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Robin Leopold sold 1,250 shares of the stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $270.09, for a total transaction of $337,612.50. Following the completion of the transaction, the insider now owns 50,377 shares of the company's stock, valued at approximately $13,606,323.93. This represents a 2.42 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 46,326 shares of company stock worth $12,448,445 in the last ninety days. 0.79% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts recently commented on JPM shares. Oppenheimer downgraded shares of JPMorgan Chase & Co. from an "outperform" rating to a "market perform" rating in a research report on Wednesday, November 20th. Wolfe Research raised shares of JPMorgan Chase & Co. from a "peer perform" rating to an "outperform" rating and set a $269.00 price objective on the stock in a research report on Friday, January 3rd. UBS Group boosted their price objective on shares of JPMorgan Chase & Co. from $276.00 to $287.00 and gave the company a "buy" rating in a research report on Thursday, January 16th. Robert W. Baird downgraded shares of JPMorgan Chase & Co. from a "neutral" rating to an "underperform" rating and set a $200.00 target price for the company. in a research report on Thursday, November 7th. Finally, Baird R W downgraded shares of JPMorgan Chase & Co. from a "hold" rating to a "strong sell" rating in a research report on Thursday, November 7th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $251.78.

JPMorgan Chase & Co. Stock Performance

Shares of NYSE JPM traded down $2.02 during trading hours on Friday, hitting $264.78. 5,916,011 shares of the stock were exchanged, compared to its average volume of 9,256,909. The company has a debt-to-equity ratio of 1.24, a current ratio of 0.88 and a quick ratio of 0.89. The company's 50 day moving average is $255.63 and its 200 day moving average is $234.48. The firm has a market capitalization of $740.35 billion, a P/E ratio of 13.41, a P/E/G ratio of 2.96 and a beta of 1.12. JPMorgan Chase & Co. has a one year low of $179.20 and a one year high of $280.25.

JPMorgan Chase & Co. (NYSE:JPM - Get Free Report) last released its earnings results on Wednesday, January 15th. The financial services provider reported $4.81 EPS for the quarter, beating the consensus estimate of $4.03 by $0.78. The firm had revenue of $42.77 billion during the quarter, compared to analysts' expectations of $41.90 billion. JPMorgan Chase & Co. had a net margin of 20.96% and a return on equity of 16.99%. The business's quarterly revenue was up 10.9% compared to the same quarter last year. During the same period in the prior year, the company earned $3.04 EPS. On average, research analysts expect that JPMorgan Chase & Co. will post 18.1 EPS for the current year.

JPMorgan Chase & Co. Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Monday, January 6th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.89%. The ex-dividend date was Monday, January 6th. JPMorgan Chase & Co.'s payout ratio is currently 25.33%.

About JPMorgan Chase & Co.

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.